Literature DB >> 16737791

Effects of riboflavin in children with complex II deficiency.

Marianna Bugiani1, Eleonora Lamantea, Federica Invernizzi, Isabella Moroni, Alberto Bizzi, Massimo Zeviani, Graziella Uziel.   

Abstract

Isolated complex II deficiency is a rare cause of mitochondrial disease in infancy and childhood. No satisfactory treatment is currently available, and affected patients undergo a relentlessly progressive motor and mental deterioration. We report on three complex II-deficient children treated with riboflavin per os, who were followed-up for a mean period of 4.5 years. In two patients with early-onset leukoencephalopathy, neurological condition remained stable or even moderately improved. In the third child, presenting in the first year of life with poor somatic growth and severe hyperlactacidemia, plasma lactate decreased to near-normal levels, and he did not develop signs of neurological involvement. Riboflavin supplementation to the growth medium of cultured fibroblasts resulted in a 2-fold increase of complex II activity in patients, but not in controls.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737791     DOI: 10.1016/j.braindev.2006.04.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  28 in total

Review 1.  Mitochondrial disorders caused by mutations in respiratory chain assembly factors.

Authors:  Francisca Diaz; Heike Kotarsky; Vineta Fellman; Carlos T Moraes
Journal:  Semin Fetal Neonatal Med       Date:  2011-06-15       Impact factor: 3.926

Review 2.  Therapies for mitochondrial diseases and current clinical trials.

Authors:  Ayman W El-Hattab; Ana Maria Zarante; Mohammed Almannai; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2017-09-18       Impact factor: 4.797

Review 3.  Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

Authors:  Adam J Kuszak; Michael Graham Espey; Marni J Falk; Marissa A Holmbeck; Giovanni Manfredi; Gerald S Shadel; Hilary J Vernon; Zarazuela Zolkipli-Cunningham
Journal:  Annu Rev Pathol       Date:  2017-11-03       Impact factor: 23.472

Review 4.  Succinate dehydrogenase - Assembly, regulation and role in human disease.

Authors:  Jared Rutter; Dennis R Winge; Joshua D Schiffman
Journal:  Mitochondrion       Date:  2010-03-10       Impact factor: 4.160

5.  Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency.

Authors:  Pilar Gonzalez-Cabo; Sheila Ros; Francesc Palau
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

6.  A modern approach to the treatment of mitochondrial disease.

Authors:  Sumit Parikh; Russell Saneto; Marni J Falk; Irina Anselm; Bruce H Cohen; Richard Haas; The Mitochondrial Medicine Society
Journal:  Curr Treat Options Neurol       Date:  2009-11       Impact factor: 3.598

Review 7.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

8.  SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy.

Authors:  Daniele Ghezzi; Paola Goffrini; Graziella Uziel; Rita Horvath; Thomas Klopstock; Hanns Lochmüller; Pio D'Adamo; Paolo Gasparini; Tim M Strom; Holger Prokisch; Federica Invernizzi; Ileana Ferrero; Massimo Zeviani
Journal:  Nat Genet       Date:  2009-05-24       Impact factor: 38.330

Review 9.  The power of yeast to model diseases of the powerhouse of the cell.

Authors:  Matthew G Baile; Steven M Claypool
Journal:  Front Biosci (Landmark Ed)       Date:  2013-01-01

10.  Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB.

Authors:  Nunziata Maio; Daniele Ghezzi; Daniela Verrigni; Teresa Rizza; Enrico Bertini; Diego Martinelli; Massimo Zeviani; Anamika Singh; Rosalba Carrozzo; Tracey A Rouault
Journal:  Cell Metab       Date:  2015-12-31       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.